Cialis

Drug: Cialis
Company: Eli Lilly
Total spend Q1, 2012: $42.3 million
Total spend Q1, 2011: $33.3 million
Watch the TV commercial here >>

The market for erectile dysfunction drugs remains strong and Cialis last year brought Lilly $1.88 billion. That was 8% of the company's revenue, although about half what Lilly generates from its antidepressant Cymbalta, which it also marketed heavily in the first quarter. Cialis earned $207 million in the first quarter, drugs.com reports, up 3.2%. Its patent on Cialis is good in the U.S. until 2017, so Lilly has about 5 more years of promising revenue even as other of its drugs lose protection.

Cialis
Read more on

Suggested Articles

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.

In a last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat rivals.